Atlas Trials

GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases

Clinical trial NCT01480583 · COMPLETED

Trial details

NCT number
NCT01480583
Sponsor
Angiochem Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerBrain Metastases
Start date
2011-10-01
Primary completion
2015-06-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.